Mohamed Yassine
Nessuna posizione attualmente
Profilo
Mohamed Yassine worked as a Senior Vice President-Medical Affairs at Aimmune Therapeutics, Inc.
Precedenti posizioni note di Mohamed Yassine
| Società | Posizione | Fine |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2022 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
- Borsa valori
- Insiders
- Mohamed Yassine
